Fintel reports that on October 27, 2025, Mizuho maintained coverage of Xcel Energy (NasdaqGS:XEL) with a Outperform ...
TipRanks on MSN
Xcel Energy resumed with an Outperform at RBC Capital
RBC Capital analyst Stephen D’Ambrisi resumed coverage of Xcel Energy (XEL) with an Outperform rating and $7 price target With the overhang of the ...
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA), a Boulder-based company that develops wound-care and dermatology products, has terminated its chief operating officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback